Short Interest in Genesco Inc. (NYSE:GCO) Rises By 8.6%

Genesco Inc. (NYSE:GCOGet Free Report) was the target of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 517,600 shares, an increase of 8.6% from the January 15th total of 476,500 shares. Currently, 5.0% of the company’s shares are sold short. Based on an average trading volume of 194,300 shares, the short-interest ratio is presently 2.7 days.

Analyst Ratings Changes

Separately, StockNews.com raised Genesco from a “hold” rating to a “buy” rating in a research report on Friday, December 6th.

Get Our Latest Stock Report on GCO

Genesco Stock Down 0.5 %

GCO stock opened at $40.69 on Tuesday. The company has a current ratio of 1.56, a quick ratio of 0.32 and a debt-to-equity ratio of 0.19. The firm has a market capitalization of $456.08 million, a PE ratio of -16.78 and a beta of 2.35. Genesco has a 1-year low of $23.21 and a 1-year high of $44.80. The business’s 50 day simple moving average is $41.58 and its 200 day simple moving average is $33.52.

Genesco (NYSE:GCOGet Free Report) last posted its earnings results on Friday, December 6th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.31. The business had revenue of $596.30 million for the quarter, compared to analyst estimates of $577.73 million. Genesco had a positive return on equity of 0.56% and a negative net margin of 1.13%. The firm’s revenue was up 2.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.57 EPS. As a group, research analysts anticipate that Genesco will post 0.94 EPS for the current year.

Insider Activity at Genesco

In other news, VP Daniel E. Ewoldsen sold 4,000 shares of Genesco stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $42.68, for a total transaction of $170,720.00. Following the transaction, the vice president now owns 41,358 shares in the company, valued at $1,765,159.44. The trade was a 8.82 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 7.09% of the stock is owned by company insiders.

Hedge Funds Weigh In On Genesco

Institutional investors and hedge funds have recently bought and sold shares of the company. Portolan Capital Management LLC bought a new position in Genesco in the 4th quarter valued at about $19,847,000. Fund 1 Investments LLC increased its stake in shares of Genesco by 1,045.4% during the 4th quarter. Fund 1 Investments LLC now owns 242,965 shares of the company’s stock worth $10,387,000 after purchasing an additional 221,752 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Genesco by 124.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 251,142 shares of the company’s stock worth $6,824,000 after purchasing an additional 139,485 shares during the last quarter. Marshall Wace LLP increased its stake in shares of Genesco by 28.6% during the 4th quarter. Marshall Wace LLP now owns 428,143 shares of the company’s stock worth $18,303,000 after purchasing an additional 95,195 shares during the last quarter. Finally, American Century Companies Inc. boosted its holdings in Genesco by 25.3% in the 4th quarter. American Century Companies Inc. now owns 276,807 shares of the company’s stock worth $11,833,000 after buying an additional 55,977 shares during the period. Institutional investors and hedge funds own 94.51% of the company’s stock.

Genesco Company Profile

(Get Free Report)

Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.

Featured Stories

Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.